Rana Mays
Dermatology · Webster, TXNPI 1801083431
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $201,823 of the $257,326 with a category attached, or 78.4%. 36 manufacturers reported payments, led by Galderma Laboratories, L.p. at 49.0% of the total. Reporting peaked in 2023 at $57,920 and has fallen 52.7% since, to $27,407 in 2025. Among dermatology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 596 payments — averaging $431.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$126K
- Amgen$87K
- Bristol Myers Squibb$30K
- UCB, Inc.$4K
- Regeneron Healthcare Solutions, Inc.$4K
- Mallinckrodt Hospital Products Inc.$2K
- plus $4K from 30 others
Across 1 payment — averaging $61.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$61
What the payments were for
- Consulting fees$21,2768%
- Speaking & faculty fees$201,82378%
- Travel & lodging$19,6978%
- Food & beverage$14,5316%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 210 | $125,998 |
| Amgen | 97 | $86,543 |
| Bristol Myers Squibb | 39 | $30,033 |
| UCB, Inc. | 34 | $4,226 |
| Regeneron Healthcare Solutions, Inc. | 11 | $4,122 |
| Mallinckrodt Hospital Products Inc. | 15 | $2,307 |
| AbbVie(2 entities) | 66 | $785 |
| Sanofi | 15 | $579 |
| Merz North America, Inc. | 8 | $464 |
| Johnson & Johnson | 24 | $413 |
| Pfizer | 22 | $391 |
| Incyte Corporation | 3 | $180 |
| Lilly USA, LLC | 9 | $170 |
| Sun Pharmaceutical Industries Inc. | 6 | $159 |
| Janssen Scientific Affairs, LLC | 1 | $150 |
| Boston Scientific | 1 | $143 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $105 |
| Prugen, Inc. Pharmaceuticals | 4 | $63 |
| Novartis | 2 | $53 |
| Arcutis Biotherapeutics, Inc. | 3 | $50 |
| Dermira, Inc. | 2 | $38 |
| Strata Skin Sciences, Inc. | 3 | $36 |
| Sensus Healthcare, Inc. | 1 | $36 |
| Almirall LLC | 2 | $34 |
| Mayne Pharma Commercial LLC | 1 | $29 |
| Genentech USA, Inc. | 1 | $28 |
| Revance Therapeutics, Inc. | 1 | $25 |
| Organon | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Alpha Orthopedic Systems | 1 | $19 |
| DUSA Pharmaceuticals, Inc. | 1 | $19 |
| Medline Industries LP | 1 | $19 |
| Medtronic | 1 | $17 |
| Convatec Inc. | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $16 |
| Fidia Pharma USA Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$257,326 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Other dermatology in Webster
- Stephen TyringWebster$880K
- Edward LainAustin$2.5M
- William CragunSan Antonio$2.2M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
- Emily BeckerSan Antonio$1.2M
- Ross RaduskyDallas$1.2M
- Joseph MerolaDallas$1.2M
- Daniel CarrascoAustin$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.